Palliative CarePAPHOMENCT06611800
Personalized Advance Prescriptions in Palliative Care at HOME: Interests and Difficulties of Its Implementation
An observational study of Palliative Care, run by Centre Hospitalier William Morey - Chalon sur Saône at 1 site in France.
Trial summary
Retrospective data collection on the files of patients cared for by the mobile palliative care team of the William Morey Hospital Center who died in 2022. Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Palliative Care
- How many people
- 256 participants
- Where
- 1 siteFrance
- Study dates
- 1 Oct 2024to 7 Oct 2024
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: Patients over the age of 18 cared for by the mobile palliative care team at the William Morey Hospital Center in Chalon sur Saône, who died between 01/01/2022 and 12/31/2022, having been cared for at least once in their place of life (home, EHPAD) with a visit or a call to the attending physician for advice
Who may be able to join
- Minimum 18 years old
- Taken care of once in their place of life by a palliative care team
- Died between 01/01/2022 and 12/31/2022 in William Morey Hospital Center
Who cannot join
None listed.
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Personalized Advance Prescriptions in Palliative Care at HOME: Interests and Difficulties of Its Implementation (PAPHOME)
Retrospective data collection on the files of patients cared for by the mobile palliative care team of the William Morey Hospital Center who died in 2022.
Read the detailed description
Retrospective selection of patients and collection of data : pathology, identified risk, presence of caregiver, end-of-life wishes, characteristics of palliative care treatment, circumstances of death. Comparison of two groups : presence or absence of personalized advance prescriptions.
- Conditions
- Palliative Care
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
| Study group | Role | What they receive |
|---|---|---|
| Presence or absence of personalized advance prescriptions | collection of data for the purpose of know the benefit of personalized advance prescriptions for patients in palliative care at home, particularly in reducing the number of visits to the emergency room and their conditions of death |
What is being measured
The primary outcome is the main question the study is designed to answer.
Know if the presence of advance prescriptions can lead to a reduction in the number of emergency admissions for an "avoidable reason" by its management by a mobile palliative care team (with a maximum of 6 months before death)
Collection of corresponding variables : presence/absence advance prescriptions ; number of emergency admissions for an "avoidable reason"
Measured: A year
Secondary outcomes (3)
Reduction in the number of emergency admissions for all reasons in their last 6 months of life.
Collection of corresponding variables
Measured: A year
Describe conditions of death: location, respect for the wishes of a death at home and notion of a calm death collected from the family
Collection of corresponding variables
Measured: A year
Describe the treatments used for PAPs: Analgesics, Anxiolytics, Anti-secretory drugs, Neuroleptics, Anti-histamines, Anti-emetics
Collection of corresponding variables
Measured: A year
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted25 Sep 2024
- Study start1 Oct 2024
- Primary completion1 Oct 2024
- Study completion7 Oct 2024
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (2)Papers the sponsor has linked to this study.
- Other trials for Palliative CareStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Retrospective
- Enrolment
- 256 participants (actual)
Sponsor and investigators
- Lead sponsor
- Centre Hospitalier William Morey - Chalon sur Saône
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Julie COLLOT, Centre Hospitalier William Morey - Chalon sur Saône
- Investigators
- Julie COLLOT, Principal investigator, Centre Hospitalier William Morey
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06611800
- Sponsor's protocol ID
- PAPHOME
- Acronym
- PAPHOME
- Status last verified
- Oct 2024
- First submitted
- 11 Jun 2024
- Last updated
- 17 Oct 2024
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Publications
Temel JS, Greer JA, Muzikansky A, Gallagher ER, Admane S, Jackson VA, Dahlin CM, Blinderman CD, Jacobsen J, Pirl WF, Billings JA, Lynch TJ. Early palliative care for patients with metastatic non-small-cell lung cancer. N Engl J Med. 2010 Aug 19;363(8):733-42. doi: 10.1056/NEJMoa1000678.
PubMed 20818875Haun MW, Estel S, Rucker G, Friederich HC, Villalobos M, Thomas M, Hartmann M. Early palliative care for adults with advanced cancer. Cochrane Database Syst Rev. 2017 Jun 12;6(6):CD011129. doi: 10.1002/14651858.CD011129.pub2.
PubMed 28603881
Study at a glance
From the registry record, last updated by the sponsor on 17 Oct 2024. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Personalized Advance Prescriptions in Palliative Care at HOME: Interests and Difficulties of Its Implementation (PAPHOME)
- ClinicalTrials.gov ID
- NCT06611800
- Acronym / sponsor ID
- PAPHOME / PAPHOME
- Conditions
- Palliative Care
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 256 participants (actual)
- Lead sponsor
- Centre Hospitalier William Morey - Chalon sur SaôneUniversity, hospital or other
- Study start
- 1 Oct 2024 (actual)
- Primary completion
- 1 Oct 2024 (actual)
- Study completion
- 7 Oct 2024 (actual)
- First posted
- 25 Sep 2024 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Retrospective data collection on the files of patients cared for by the mobile palliative care team of the William Morey Hospital Center who died in 2022.
Detailed description
Retrospective selection of patients and collection of data : pathology, identified risk, presence of caregiver, end-of-life wishes, characteristics of palliative care treatment, circumstances of death. Comparison of two groups : presence or absence of personalized advance prescriptions.
Study design
- Observational model
- Cohort
- Time perspective
- Retrospective
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Presence or absence of personalized advance prescriptions | – | –collection of data for the purpose of know the benefit of personalized advance prescriptions for patients in palliative care at home, particularly in reducing the number of visits to the emergency room and their conditions of death |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- Patients over the age of 18 cared for by the mobile palliative care team at the William Morey Hospital Center in Chalon sur Saône, who died between 01/01/2022 and 12/31/2022, having been cared for at least once in their place of life (home, EHPAD) with a visit or a call to the attending physician for advice
Key inclusion criteria (3 listed)
- Minimum 18 years old
- Taken care of once in their place of life by a palliative care team
- Died between 01/01/2022 and 12/31/2022 in William Morey Hospital Center
Key exclusion criteria (0 listed)
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Know if the presence of advance prescriptions can lead to a reduction in the number of emergency admissions for an "avoidable reason" by its management by a mobile palliative care team (with a maximum of 6 months before death)
Time frame: A year
Collection of corresponding variables : presence/absence advance prescriptions ; number of emergency admissions for an "avoidable reason"
3 secondary outcomes
Reduction in the number of emergency admissions for all reasons in their last 6 months of life.
Time frame: A year
Describe conditions of death: location, respect for the wishes of a death at home and notion of a calm death collected from the family
Time frame: A year
Describe the treatments used for PAPs: Analgesics, Anxiolytics, Anti-secretory drugs, Neuroleptics, Anti-histamines, Anti-emetics
Time frame: A year
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 17 Oct 2024.
- Results publication: PubMed 20818875Temel JS, Greer JA, Muzikansky A, Gallagher ER, Admane S, Jackson VA, Dahlin CM, Blinderman CD, Jacobsen J, Pirl WF, Billings JA, Lynch TJ. Early palliative care for patients with metastatic non-small-cell lung cancer. N Engl J Med. 2010 Aug 19;363(8):733-42. doi: 10.1056/NEJMoa1000678.
- Results publication: PubMed 28603881Haun MW, Estel S, Rucker G, Friederich HC, Villalobos M, Thomas M, Hartmann M. Early palliative care for adults with advanced cancer. Cochrane Database Syst Rev. 2017 Jun 12;6(6):CD011129. doi: 10.1002/14651858.CD011129.pub2.
- Individual participant dataSharing planned: No
Related trials for Palliative Care
Not yet recruitingObservational study
IN-TALK: Co-producing a Hospice Intimacy Support Toolkit in England
Communication About Intimacy Needs in Hospice and Palliative Care
Not yet recruitingPhase 2
Psilocybin With Psychotherapy for Improving Chronic Pain in Cancer Patients Requiring Opioids
Hematopoietic and Lymphatic System Neoplasm, Malignant Solid Neoplasm
RecruitingPhase 1/2
Interstitial Photodynamic Therapy Following Palliative Radiotherapy in Treating Patients With Inoperable Malignant Central Airway Obstruction
Malignant Solid Neoplasm
Active, not recruiting
LiverPAL: A Trial of Inpatient Palliative Care for Patients With Advanced Liver Disease
Liver Disease Chronic, End Stage Liver DIsease
Not yet recruiting
Comparing Radiotherapy Dose Strategies for Symptom Relief in Large Solid Tumors
Solid Tumor
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Julie COLLOT principal investigator
Centre Hospitalier William Morey
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Palliative Care, run by Centre Hospitalier William Morey - Chalon sur Saône at 1 site in France.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 0 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 17 Oct 2024. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Know if the presence of advance prescriptions can lead to a reduction in the number of emergency admissions for an "avoidable reason" by its management by a mobile palliative care team (with a maximum of 6 months before death) (time frame: A year). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT06611800, which also lists 2 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 17 Oct 2024.